A new edition of the WHO classification of tumours of the CNS was published in 2021.
Although the previous edition of this classification was published just 5 years earlier, in …

Gliomas are the most frequent intrinsic tumours of the central nervous system and
encompass two principle subgroups: diffuse gliomas and gliomas showing a more …

Advances in the understanding of the molecular biology of central nervous system (CNS)
tumors prompted a new World Health Organization (WHO) classification scheme in 2021 …

The new WHO classification of diffuse gliomas has been refined and now includes the
1p/19q codeletion, IDH1/2 mutation, and histone H3-K27M mutation. Our objective was to …

Insights into the molecular underpinnings of primary central nervous system tumors have
radically changed the approach to tumor diagnosis and classification. Diagnostic emphasis …

Recent updating of the World Health Organization (WHO) classification of central nervous
system (CNS) tumors in 2016 demonstrates the first organized effort to restructure brain …

Practical implications of integrated glioma classification a... : Current Opinion in Oncology
Practical implications of integrated glioma classification according to the World Health …

Codeletion of chromosomal arms 1p and 19q, in conjunction with a mutation in the isocitrate
dehydrogenase 1 or 2 gene, is the molecular diagnostic criterion for oligodendroglioma, IDH …

Purpose: The integrated histopathologic and molecular diagnoses of the 2016 WHO
classification of central nervous system tumors have revolutionized patient care by …

Context.—In the recently updated World Health Organization (WHO) classification of central
nervous system tumors, our concept of infiltrating gliomas as a molecular dichotomy …